FLXN
Flexion Therapeutics Inc
Price:  
9.12 
USD
Volume:  
17,935,500.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FLXN WACC - Weighted Average Cost of Capital

The WACC of Flexion Therapeutics Inc (FLXN) is 7.2%.

The Cost of Equity of Flexion Therapeutics Inc (FLXN) is 8.10%.
The Cost of Debt of Flexion Therapeutics Inc (FLXN) is 7.50%.

Range Selected
Cost of equity 6.10% - 10.10% 8.10%
Tax rate 27.00% - 27.00% 27.00%
Cost of debt 7.00% - 8.00% 7.50%
WACC 5.7% - 8.7% 7.2%
WACC

FLXN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 4.2% 5.2%
Adjusted beta 0.68 1.13
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 10.10%
Tax rate 27.00% 27.00%
Debt/Equity ratio 0.5 0.5
Cost of debt 7.00% 8.00%
After-tax WACC 5.7% 8.7%
Selected WACC 7.2%